• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Korean Biotech Talks About U.S. Company Launch

Article

Pharmaceutical Executive

Enzychem Lifesciences explains why the Korean biotech decided to open U.S. headquarters, as well as gives an update on their most recent clinical trials.

Enzychem Lifesciences’ Chairman and CEO, Ki-Young Sohn explains why the Korean biotech decided to open U.S. headquarters, as well as gives an update on their most recent clinical trials.

He spoke to Pharm Exec during a company event in New York City.

 

 

 

Recent Videos
Paul Howe
Paul Howe
Ash Shehata
Related Content
Exploring Biopharma's Dealmaking Terrain, Roadmap in China

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

Adam Zhang Yu
January 27th 2025
Article

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Mike Ryan

Global Expansion: Q&A with Mike Ryan

Mike Hollan
November 13th 2024
Article

EVERSANA's Ryan discusses the company’s recent expansion into new markets in Europe.

Vikram Anand

The Global Stage: Q&A with EVERSANA’s Vikram Anand

Mike Hollan
October 29th 2024
Article

The president of compliance services discusses the company’s recent expansion into new markets.

Challenges of Unclear Product Labeling on Patient Outcomes

Challenges of Unclear Product Labeling on Patient Outcomes

Don Tracy, Associate Editor
October 8th 2024
Article

Laura Johnson, senior director, sales, life sciences, Loftware, discusses scenarios where unclear labeling led to challenges for patient outcomes.